CASC

Cascadian Therapeutics, Inc.

CASC

Delisted

CASC was delisted on the 8th of March, 2018.

93 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 43 reducing their positions, and 18 closing their positions.

2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

Holders Change

-7

Holders Change %

-7%

% of All Funds

2.6%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-33.33%

% of All Funds

0.06%

New

Increased

Reduced

Closed

Calls

$890K

Puts

$296K

Net Calls

+$594K

Net Calls Change

-$661K

Top Buyers

1	BI 1 BVF Inc San Francisco, California	$44.8M
2	CS 2 Candriam SCA Strassen, Luxembourg, Luxembourg	$2.87M
3	EC 3 EcoR1 Capital San Francisco, California	$2.59M
4	LOAMU 4 Lombard Odier Asset Management (USA) New York	$1.45M
5	5 State Street Boston, Massachusetts	$4.34M

Top Sellers

1	BC 1 Broadfin Capital New York	$1.62M
2	ACP 2 Acuta Capital Partners Redwood City, California	$0
3	3 Franklin Resources San Mateo, California	$18.9M
4	BIT 4 BlackRock Institutional Trust San Francisco, California	$7.82M
5	RG 5 Redmile Group San Francisco, California	$9.91M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	BI 1 BVF Inc San Francisco, California	$44.8M	16,360,538	+6,606,360	+68%
2	2 Franklin Resources San Mateo, California	$18.9M	6,899,600	-655,900	-9%
3	ACA 3 Avoro Capital Advisors New York	$15.1M	5,506,618	-110,385	-2%
4	RG 4 Redmile Group San Francisco, California	$9.91M	3,614,990	-549,888	-13%
5	5 Vanguard Group Malvern, Pennsylvania	$8.93M	3,260,775	+86,873	+3%
6	BIT 6 BlackRock Institutional Trust San Francisco, California	$7.82M	2,854,314	-633,534	-18%
7	BFA 7 BlackRock Fund Advisors San Francisco, California	$6.75M	2,463,053	-162,078	-6%
8	8 State Street Boston, Massachusetts	$4.34M	1,582,693	+174,144	+12%
9	GCM 9 Gruss Capital Management New York	$3.03M	1,106,000	–	–
10	CS 10 Candriam SCA Strassen, Luxembourg, Luxembourg	$2.87M	1,047,000	+1,047,000	New
11	11 Northern Trust Chicago, Illinois	$2.71M	987,831	+14,164	+1%
12	EC 12 EcoR1 Capital San Francisco, California	$2.59M	943,500	+943,500	New
13	QF 13 QVT Financial New York	$1.68M	614,370	+147,624	+32%
14	14 Geode Capital Management Boston, Massachusetts	$1.67M	608,641	+5,807	+1%
15	BC 15 Broadfin Capital New York	$1.62M	592,200	-1,107,800	-65%
16	16 JPMorgan Chase & Co New York	$1.55M	565,228	-9,064	-2%
17	17 Deutsche Bank Frankfurt Am Main Ge, Germany	$1.51M	551,871	+19,086	+4%
18	LOAMU 18 Lombard Odier Asset Management (USA) New York	$1.45M	530,286	+230,286	+77%
19	PA 19 Perceptive Advisors New York	$1.38M	3,546,897	+200,000	+6%
20	BCM 20 Bridgeway Capital Management Houston, Texas	$1.19M	432,588	-84,000	-16%
21	21 D.E. Shaw & Co New York	$1.1M	400,375	-144,714	-27%
22	PCM 22 Perkins Capital Management Wayzata, Minnesota	$1.07M	390,650	-13,763	-3%
23	23 Renaissance Technologies New York	$931K	339,800	-134,392	-28%
24	24 Bank of New York Mellon New York	$917K	334,498	-75,721	-18%
25	BIM 25 BlackRock Investment Management Wilmington, Delaware	$893K	325,738	-34,098	-9%

Cascadian Therapeutics, Inc. CASC

Top Buyers

Top Sellers

Cascadian Therapeutics, Inc.

CASC